FANCG antibody (C-Term)
Quick Overview for FANCG antibody (C-Term) (ABIN966129)
Target
See all FANCG AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- C-Term
-
Immunogen
- Polyclonal antibody produced in rabbits immunizing with a synthetic peptide corresponding to C-terminal residues of human FANCG (Fanconi anemia group G protein)
-
-
-
-
Restrictions
- For Research Use only
-
-
-
Storage
- 4 °C
-
-
-
: "X-linked inheritance of Fanconi anemia complementation group B." in: Nature genetics, Vol. 36, Issue 11, pp. 1219-24, (2004) (PubMed).
: "Spectrum of mutations in the Fanconi anaemia group G gene, FANCG/XRCC9." in: European journal of human genetics : EJHG, Vol. 8, Issue 11, pp. 861-8, (2000) (PubMed).
: "Fanconi anemia proteins FANCA, FANCC, and FANCG/XRCC9 interact in a functional nuclear complex." in: Molecular and cellular biology, Vol. 19, Issue 7, pp. 4866-73, (1999) (PubMed).
-
-
- FANCG (Fanconi Anemia Complementation Group G (FANCG))
-
Alternative Name
- FANCG
-
Background
-
DNA repair protein that may operate in a postreplication repair or a cell cycle checkpoint function. FANCG may be implicated in interstrand DNA cross-link repair and in the maintenance of normal chromosome stability. FANCG is a andidate tumor suppressor gene. FANCG belongs to the multisubunit FA complex composed of FANCA, FANCB, FANCC, FANCE, FANCF, FANCG, FANCL/PHF9 and FANCM. The complex is not found in FA patients. The major form is nuclear. The minor form is cytoplasmic. Highly expressed in testis and thymus. Found in lymphoblasts. Defects in FANCG are a cause of Fanconi anemia (FA)
Synonym: XRCC9 (DNA repair protein XRCC9) -
Pathways
- DNA Damage Repair
Target
-